Metastatic hepatic (liver) cancer occurs when cancer that originated from another organ spreads and infects the liver. It is also commonly known as secondary liver cancer as the cancer did not begin in the liver. The liver is a common place for this to occur as its large size as well as high blood flow makes it especially vulnerable to infection by way of cancer cells moving through the blood stream. Metastatic hepatic cancer is most commonly caused by colorectal, breast, and lung cancer. Treatments for liver metastases include surgery, chemotherapy, radiation therapy, biologic therapies, and image-guided therapies.
Hepatic Cancer Metastatic Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Hepatic Cancer Metastatic below!
For more information on how to use Laverne, please read the How to Guide.
We have 2849 products for the study of Hepatic Cancer Metastatic that can be applied to Western Blot, Immunocytochemistry/Immunofluorescence, Flow Cytometry, Immunohistochemistry from our catalog of antibodies and ELISA kits.